End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- AUD | -.--% |
|
-.--% | -.--% |
Sales 2024 * | 838M 565M | Sales 2025 * | 799M 538M | Capitalization | 249M 167M |
---|---|---|---|---|---|
Net income 2024 * | 175M 118M | Net income 2025 * | 221M 149M | EV / Sales 2024 * | 0.3 x |
Net cash position 2024 * | 305K 205K | Net cash position 2025 * | 127M 85.61M | EV / Sales 2025 * | 0.15 x |
P/E ratio 2024 * |
1.59
x | P/E ratio 2025 * |
1.32
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 57.49% |
Latest transcript on EHR RESO
Managers | Title | Age | Since |
---|---|---|---|
Kim Truter
CEO | Chief Executive Officer | - | 20-09-21 |
Brad Baylis
DFI | Director of Finance/CFO | - | 23-04-25 |
Jeremy Taylor
CTO | Chief Tech/Sci/R&D Officer | - | 21-11-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeremy King
BRD | Director/Board Member | 50 | Mar. 31 |
Marc Dorion
BRD | Director/Board Member | - | 20-07-04 |
William O'Keeffe
CHM | Chairman | - | 17-06-14 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 5.45B | |
-49.71% | 88.56M |
- Stock Market
- Equities
- CMT Stock
- EHX Stock